Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected
Authors
Keywords
SARS-CoV-2, COVID-19, Immunogenicity, Efficacy, mRNA-1273 vaccine
Journal
JOURNAL OF INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-23
DOI
10.1016/j.jinf.2021.08.031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
- (2021) Charlotte Manisty et al. LANCET
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: People who have had infection might only need one dose of mRNA vaccine
- (2021) Jacqui Wise BMJ-British Medical Journal
- Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
- (2021) Marie Tré-Hardy et al. JOURNAL OF INFECTION
- mRNA SARS-CoV-2 Immunization Confers Robust Antibody Response in Occupational Healthcare Workers and Fosters Workplace Safety
- (2021) Bart O. Iddins et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
- (2021) Gabriele Anichini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study
- (2021) Santiago Romero-Brufau et al. BMJ-British Medical Journal
- The COVID-19 Vaccines: Recent Development, Challenges and Prospects
- (2021) Yuxin Yan et al. Vaccines
- Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers
- (2021) Gian Luca Salvagno et al. JOURNAL OF INFECTION
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers
- (2021) Evangelos Terpos et al. Cells
- Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody
- (2020) Marie Tré-Hardy et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- COVID-19 in Healthcare Workers: A Living Systematic Review and Meta-analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes
- (2020) Sergio Alejandro Gómez-Ochoa et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search